The relevance of engagement: maximising the benefits of screening for major depressive disorder
Por:
Arias-de la Torre J, Ronaldson A, Dregan A, Serrano-Blanco A, Valderas JM, Martín V and Alonso J
Publicada:
1 abr 2025
Ahead of Print:
29 abr 2025
Resumen:
Filiaciones:
Arias-de la Torre J:
Care in Long Term Conditions Research Division, King's College London, London, UK
Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK
CIBER Epidemiology and Public Health, Madrid, Spain
and Institute of Biomedicine, Universidad de León, León, Spain
Ronaldson A:
Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK
Dregan A:
Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK
Serrano-Blanco A:
CIBER Epidemiology and Public Health, Madrid, Spain
and Institut de Recerca Sant Joan de Déu, Parc Sanitari Sant Joan de Déu, Barcelona, Spain
Valderas JM:
Department of Medicine, National University of Singapore, Singapore
Department of Family Medicine, National University Health System, Singapore
and Centre for Research in Health Systems Performance, National University Health System, Singapore
Martín V:
CIBER Epidemiology and Public Health, Madrid, Spain
and Institute of Biomedicine (IBIOMED), Universidad de León, León, Spain
Alonso J:
CIBER Epidemiology and Public Health, Madrid, Spain
Health Services Research Group, Hospital del Mar Medical Research Institute, Barcelona, Spain
and Department of Medical and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain
Bronze
|